Clinical Trial

GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

On-demand video webcast now available here  LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI)…

10 months ago

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

 New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders…

10 months ago

Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference

On-demand video webcast now available here BOSTON and LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX),…

10 months ago

FDA Sets Meeting Date with Izotropic

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)…

10 months ago

Health Union Launches Online Community for Opioid Use Disorder

PHILADELPHIA, Feb. 18, 2025 /PRNewswire/ -- Health Union, the leading digital health company for online community-based activation and data, has launched…

10 months ago

Virtual Therapy Market to Reach USD 1.62 Billion by 2031: Growing Demand for Digital Mental Health Solutions | Valuates Reports

Virtual Therapy Market is Segmented by Type (Non Immersive, Fully Immersive), by Application (Psychotherapy, Virtual Rehabilitation, PTSD, Occupational Therapy, Lesion…

10 months ago

Global Genes Awarded Prestigious $1.5 Million Technology Grant by the Chan Zuckerberg Initiative

Grant will accelerate expansion of RARE-X patient data platform WASHINGTON, Feb. 18, 2025 /PRNewswire/ -- Global Genes, the rare disease…

10 months ago

BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD

Commercial success of VINIA validates the power of BioHarvest's patented Botanical Synthesis technology to produce valuable plant-based Compounds at industrial…

10 months ago

Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products

Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is proud to announce a strategic…

10 months ago

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced the…

10 months ago